| RS142265031 |
GYS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease due to muscle and heart glycogen synthase deficiency, GYS1-related disorder |
| RS142265349 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS142265627 |
SLC52A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Brown-Vialetto-van Laere syndrome 1, Inborn genetic diseases |
| RS1422656895 |
NFIA
|
Health Risk |
Pathogenic/Likely pathogenic |
Brain malformations with or without urinary tract defects, NFIA-related disorder |
| RS142266106 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, Inborn genetic diseases |
| RS142266408 |
POLR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Acrofacial dysostosis Cincinnati type, Inborn genetic diseases |
| RS142266428 |
KLF11
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 7, Maturity-onset diabetes of the young type 7 |
| RS142268279 |
TNPO3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant limb-girdle muscular dystrophy type 1F, Autosomal dominant limb-girdle muscular dystrophy type 1F |
| RS142269166 |
JAK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Thrombocythemia 3, Thrombocythemia 3 |
| RS142269451 |
SLC6A19
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1422698524 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, adult type |
| RS142269885 |
CLN8
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis 8, Neuronal ceroid lipofuscinosis |
| RS1422698928 |
RPIA
|
Health Risk |
Pathogenic |
Deficiency of ribose-5-phosphate isomerase, Deficiency of ribose-5-phosphate isomerase |
| RS142270619 |
SLC7A9
|
Health Risk |
Likely pathogenic |
— |
| RS1422720020 |
SMPD1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type A |
| RS142272329 |
SLC1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dicarboxylic aminoaciduria, Dicarboxylic aminoaciduria |
| RS1422723344 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia |
| RS1422724926 |
SYNE1
|
Health Risk |
Likely pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS142272833 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Monogenic diabetes, Maturity-onset diabetes of the young |
| RS142272846 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic cardiomyopathy with wooly hair and keratoderma, Arrhythmogenic right ventricular dysplasia 8 |
| RS1422731756 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic cardiomyopathy with wooly hair and keratoderma, Arrhythmogenic right ventricular dysplasia 8 |
| RS1422732315 |
ADAM9
|
Health Risk |
Pathogenic |
— |
| RS1422733588 |
TFR2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary hemochromatosis, Hemochromatosis type 3 |
| RS142274277 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS142274716 |
F13A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Factor XIII, A subunit |
| RS1422752351 |
KMT2D
|
Health Risk |
Pathogenic/Likely pathogenic |
Kabuki syndrome, Kabuki syndrome 1 |
| RS1422757569 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS142276415 |
FAT2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS142276590 |
PIGO
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperphosphatasia with intellectual disability syndrome 2, Hyperphosphatasia with intellectual disability syndrome 2 |
| RS142276689 |
SCN10A
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome, Cardiovascular phenotype |
| RS1422767764 |
GJB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 1A, Nonsyndromic genetic hearing loss |
| RS142276972 |
COG5
|
Health Risk |
Conflicting classifications of pathogenicity |
COG5-congenital disorder of glycosylation, Inborn genetic diseases |
| RS142277402 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS1422776122 |
AP5Z1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 48, Hereditary spastic paraplegia 48 |
| RS142277857 |
C2CD3
|
Health Risk |
Conflicting classifications of pathogenicity |
C2CD3-related disorder, C2CD3-related disorder |
| RS1422779785 |
MED12
|
Health Risk |
Conflicting classifications of pathogenicity |
FG syndrome, FG syndrome |
| RS142278066 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Monogenic diabetes |
| RS142278631 |
NSD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1422791271 |
MFSD8
|
Health Risk |
Likely pathogenic |
— |
| RS1422797135 |
ITGB4
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa with pyloric atresia, Junctional epidermolysis bullosa with pyloric atresia |
| RS142279745 |
HDAC4
|
Health Risk |
Conflicting classifications of pathogenicity |
HDAC4-related disorder, HDAC4-related disorder |
| RS142279746 |
SMARCE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial meningioma, Hereditary cancer-predisposing syndrome |
| RS142280455 |
AR
|
Health Risk |
Conflicting classifications of pathogenicity |
Non-obstructive azoospermia, Prostate cancer |
| RS1422809057 |
GDF6
|
Health Risk |
Conflicting classifications of pathogenicity |
Isolated microphthalmia 4, Microphthalmia |
| RS1422814635 |
TERT
|
Health Risk |
Pathogenic/Likely pathogenic |
Abnormal pulmonary interstitial morphology, Short telomere length |
| RS1422817588 |
BMP1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS142282413 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome, Usher syndrome |
| RS142282494 |
CYP24A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1422829075 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS142283122 |
TMEM67
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Meckel-Gruber syndrome |
| RS142283145 |
GNPAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhizomelic chondrodysplasia punctata type 2, Inborn genetic diseases |
| RS1422834817 |
EMD
|
Health Risk |
Pathogenic |
X-linked Emery-Dreifuss muscular dystrophy, X-linked Emery-Dreifuss muscular dystrophy |
| RS142284018 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS1422851315 |
FBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital contractural arachnodactyly, Familial thoracic aortic aneurysm and aortic dissection |
| RS142285373 |
CHAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial infantile myasthenia, Inborn genetic diseases |
| RS142285781 |
UBR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Johanson-Blizzard syndrome, UBR1-related disorder |
| RS142285791 |
PEX14
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder, complementation group K |
| RS142285818 |
RHO
|
Health Risk |
Pathogenic |
11 conditions, Pigmentary retinal dystrophy |
| RS142286187 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypokalemic periodic paralysis, type 1 |
| RS142286229 |
LAMA1
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA1-related disorder, Optic atrophy |
| RS1422867920 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia type I, Citrullinemia type I |
| RS142287264 |
SRCAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental delay, hypotonia |
| RS142287570 |
GCM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypoparathyroidism, Hyperparathyroidism 4 |
| RS1422876107 |
DICER1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, DICER1-related tumor predisposition |
| RS142287778 |
KMT2C
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1422879641 |
HAMP
|
Health Risk |
Pathogenic |
Hemochromatosis, juvenile |
| RS142288050 |
TIMP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Sorsby fundus dystrophy, Sorsby fundus dystrophy |
| RS142288285 |
FLCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Birt-Hogg-Dube syndrome, Familial spontaneous pneumothorax |
| RS142288625 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Schwartz-Jampel syndrome, Lethal Kniest-like syndrome |
| RS1422886839 |
FLT4
|
Health Risk |
Pathogenic |
Congenital heart defects, multiple types |
| RS1422887607 |
MBD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 1 |
| RS142289138 |
SUCLA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Global developmental delay, Mitochondrial DNA depletion syndrome |
| RS1422891600 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS142289638 |
DYSF
|
Health Risk |
Pathogenic |
— |
| RS1422897832 |
UNC13D
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 3, Familial hemophagocytic lymphohistiocytosis 3 |
| RS142289802 |
FANCB
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group B, VACTERL association |
| RS1422900655 |
RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Retinoblastoma |
| RS1422902558 |
PIEZO1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS142290596 |
RAB23
|
Health Risk |
Conflicting classifications of pathogenicity |
RAB23-related Carpenter syndrome, Carpenter syndrome |
| RS1422910994 |
LRRK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant Parkinson disease 8, Autosomal dominant Parkinson disease 8 |
| RS142291440 |
TK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial disease, Mitochondrial disease |
| RS1422917398 |
NOTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adams-Oliver syndrome 5, Aortic valve disease 1 |
| RS142292210 |
CUBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Imerslund-Grasbeck syndrome, Inborn genetic diseases |
| RS142292491 |
SMAD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Generalized juvenile polyposis/juvenile polyposis coli |
| RS142292859 |
SLC39A14
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Congenital heart disease |
| RS142293185 |
MYO7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1, Autosomal recessive nonsyndromic hearing loss 2 |
| RS1422935645 |
ABCC9
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1O, Dilated cardiomyopathy 1O |
| RS142293594 |
SRA1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS142293829 |
MBD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 1 |
| RS142293909 |
ADAMTS13
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Upshaw-Schulman syndrome |
| RS142294586 |
GNAI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1422949741 |
HCFC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Methylmalonic acidemia with homocystinuria, type cblX |
| RS142295786 |
CCDC88C
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia type 40, Hydrocephalus |
| RS142296092 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS1422977131 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS1422978230 |
HSPB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease axonal type 2F |
| RS1422979746 |
CASQ1
|
Health Risk |
Likely pathogenic |
Myopathy due to calsequestrin and SERCA1 protein overload, Myopathy due to calsequestrin and SERCA1 protein overload |
| RS1422984777 |
NAF1
|
Health Risk |
Likely risk allele |
Pulmonary fibrosis, Pulmonary fibrosis |
| RS142299109 |
SLC45A2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS142299289 |
CFAP44
|
Health Risk |
Pathogenic |
— |